Shannon Thyme Klinger insider trades: Moderna (MRNA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Shannon reports to the SEC
Open-market buys and sales
28 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | MRNA | ↓ Sell | 3,471 | $139.95 | $486K | Direct | Sep 3, 2026 (2d) |
| Jun 4, 2026 | MRNA | ↓ Sell | 3,471 | $50.00 | $174K | Direct | Jun 8, 2026 (4d) |
| Mar 2, 2026 | MRNA | ↓ Sell | 13,885 | $52.29 | $726K | Direct | Mar 3, 2026 (1d) |
| Dec 9, 2024 | MRNA | ↓ Sell | 529 | $44.68 | $24K | Direct | Dec 10, 2024 (1d) |
| Dec 3, 2024 | MRNA | ↓ Sell | 112 | $43.30 | $5K | Direct | Dec 4, 2024 (1d) |
| Nov 29, 2024 | MRNA | ↓ Sell | 1,418 | $42.79 | $61K | Direct | Dec 2, 2024 (3d) |
| Sep 9, 2024 | MRNA | ↓ Sell | 551 | $73.57 | $41K | Direct | Sep 10, 2024 (1d) |
| Sep 3, 2024 | MRNA | ↓ Sell | 114 | $76.99 | $9K | Direct | Sep 4, 2024 (1d) |
| Aug 29, 2024 | MRNA | ↓ Sell | 162 | $78.03 | $13K | Direct | Aug 30, 2024 (1d) |
| Aug 28, 2024 | MRNA | ↓ Sell | 1,319 | $79.39 | $105K | Direct | Aug 29, 2024 (1d) |
| Jun 10, 2024 | MRNA | ↓ Sell | 5,178 | $148.09 | $767K | Direct | Jun 11, 2024 (1d) |
| Jun 3, 2024 | MRNA | ↓ Sell | 122 | $140.72 | $17K | Direct | Jun 4, 2024 (1d) |
| May 29, 2024 | MRNA | ↓ Sell | 183 | $144.50 | $26K | Direct | May 30, 2024 (1d) |
| May 28, 2024 | MRNA | ↓ Sell | 1,296 | $162.47 | $211K | Direct | May 29, 2024 (1d) |
| Mar 8, 2024 | MRNA | ↓ Sell | 544 | $99.05 | $54K | Direct | Mar 11, 2024 (3d) |
| Mar 4, 2024 | MRNA | ↓ Sell | 117 | $94.34 | $11K | Direct | Mar 5, 2024 (1d) |
| Feb 29, 2024 | MRNA | ↓ Sell | 670 | $94.57 | $63K | Direct | Mar 1, 2024 (1d) |
| Dec 8, 2023 | MRNA | ↓ Sell | 563 | $79.09 | $45K | Direct | Dec 11, 2023 (3d) |
| Dec 4, 2023 | MRNA | ↓ Sell | 111 | $79.31 | $9K | Direct | Dec 5, 2023 (1d) |
| Sep 8, 2023 | MRNA | ↓ Sell | 557 | $107.22 | $60K | Direct | Sep 11, 2023 (3d) |
| Sep 5, 2023 | MRNA | ↓ Sell | 115 | $111.44 | $13K | Direct | Sep 6, 2023 (1d) |
| Jun 8, 2023 | MRNA | ↓ Sell | 565 | $124.09 | $70K | Direct | Jun 9, 2023 (1d) |
| Jun 2, 2023 | MRNA | ↓ Sell | 110 | $130.32 | $14K | Direct | Jun 5, 2023 (3d) |
| Mar 8, 2023 | MRNA | ↓ Sell | 561 | $141.51 | $79K | Direct | Mar 9, 2023 (1d) |
| Mar 2, 2023 | MRNA | ↓ Sell | 459 | $136.43 | $63K | Direct | Mar 3, 2023 (1d) |
| Dec 8, 2022 | MRNA | ↓ Sell | 490 | $179.15 | $88K | Direct | Dec 9, 2022 (1d) |
| Sep 8, 2022 | MRNA | ↓ Sell | 478 | $137.44 | $66K | Direct | Sep 9, 2022 (1d) |
| Jun 8, 2022 | MRNA | ↓ Sell | 1,265 | $148.12 | $187K | Direct | Jun 9, 2022 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MRNA insiders
Open-market trades in the last 12 months
About Shannon Thyme Klinger's insider trades
Shannon Thyme Klinger is Chief Legal Officer at Moderna (MRNA). Since Jun 8, 2022, Shannon has reported no open-market purchases and 28 sales worth $3.5M on SEC Form 4. In the last 12 months: 3 sales ($1.4M).
Their filings also include option exercises (44 filings), shares withheld for taxes (20 filings), grants and awards (9 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MRNA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.